Related Experiment Video
Updated: Dec 19, 2025
Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Mahlet Z Tamirat1, Kari J Kurppa2, Klaus Elenius3
1Structural Bioinformatics Laboratory, Biochemistry, Faculty of Science and Engineering, Åbo Akademi University.
Abstract:
Numerous somatic mutations occurring in the epidermal growth factor receptor (EGFR) family (ErbB) of receptor tyrosine kinases (RTK) have been reported from cancer patients, although relatively few have been tested and shown to cause functional changes in ErbBs. The ErbB receptors are dimerized and activated upon ligand binding, and dynamic conformational changes of the receptors are inherent for induction of downstream signaling. For two mutations shown experimentally to alter EGFR function, A702V and the Δ746ELREA750 deletion mutation, we illustrate in the following protocol how molecular dynamics (MD) simulations can probe the (1) conformational stability of the mutant tyrosine kinase structure in comparison with wild-type EGFR; (2) structural consequences and conformational transitions and their relationship to observed functional changes; (3) effects of mutations on the strength of binding ATP as well as for binding between the kinase domains in the activated asymmetric dimer; and (4) effects of the mutations on key interactions within the EGFR binding site associated with the activated enzyme. The protocol provides a detailed step-by-step procedure as well as guidance that can be more generally useful for investigation of protein structures using MD simulations as a means to probe structural dynamics and the relationship to biological function.
Insights
Molecular dynamics simulations reveal how specific epidermal growth factor receptor (EGFR) mutations impact protein stability and function. This study provides a protocol for investigating EGFR mutations and their effects on kinase activity.
Area of Science:
- Biochemistry
- Molecular Biology
- Computational Biology
Background:
- Somatic mutations in the epidermal growth factor receptor (EGFR) family (ErbB) are common in cancer.
- Few mutations have been functionally characterized, despite their prevalence.
- EGFR receptor dimerization and conformational changes are critical for downstream signaling.
Purpose of the Study:
- To investigate the structural and functional consequences of specific EGFR mutations (A702V and Δ746ELREA750) using molecular dynamics (MD) simulations.
- To establish a generalizable protocol for using MD simulations to study protein dynamics and their relationship to biological function.
- To analyze the impact of mutations on EGFR conformational stability, ATP binding, dimer interactions, and key binding site interactions.
Main Methods:
- Molecular dynamics (MD) simulations were employed to analyze wild-type and mutant EGFR tyrosine kinase structures.
- Simulations probed conformational stability, structural transitions, and binding affinities (ATP and dimer interfaces).
- Key interactions within the EGFR binding site were analyzed in the context of activated enzyme conformations.
Main Results:
- MD simulations provided insights into the conformational stability of mutant EGFR compared to wild-type.
- The study elucidated structural consequences and conformational transitions linked to observed functional changes in mutant EGFR.
- Effects of mutations on ATP binding, kinase domain dimerization, and critical binding site interactions were quantified.
Conclusions:
- Molecular dynamics simulations are a powerful tool for dissecting the functional impact of EGFR mutations.
- This protocol offers a framework for investigating protein dynamics and structure-function relationships in other receptor tyrosine kinases.
- Understanding mutation-induced changes in EGFR is crucial for developing targeted cancer therapies.
More Related Videos
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
